The pharmacy sector in Serbia has reported impressive financial results, with net profits reaching approximately 3.5 billion dinars and revenue growth of around 12%. These figures highlight the sector’s status as one of the most profitable areas within the domestic healthcare economy, surprising even industry experts.
This robust performance is particularly noteworthy given the backdrop of regulated pricing, increasing labor costs, and ongoing reimbursement limitations. Retail pharmacies operate at a critical juncture between public policy and private consumer demand, facing capped margins where operational efficiency is essential for survival.
Several key factors contribute to this resilience. The demographic trend of an ageing population in Serbia is driving a consistent demand for chronic therapies. Additionally, public health challenges have increased consumer reliance on pharmacy networks. Pharmacies are also diversifying their offerings by expanding into non-prescription products, medical devices, supplements, and personal care items that typically yield higher profit margins and face fewer regulatory hurdles.
Operational consolidation within the sector has further enhanced profitability. Larger pharmacy chains have optimized procurement, logistics, and inventory management to achieve efficiencies in a market previously marked by fragmentation. This consolidation has enabled leading operators to absorb wage increases—often exceeding 10% year-on-year in urban areas—without significantly impacting their profitability.
However, the success of private pharmacies contrasts sharply with the struggles faced by public pharmacy systems like Apoteka Beograd, which grapple with legacy debt, governance issues, and legal challenges. In contrast, private operators enjoy cleaner balance sheets and greater pricing flexibility under existing regulations. This disparity raises concerns about the long-term viability of the current public pharmacy model.
From a broader economic perspective, the performance of pharmacy retail underscores a recurring theme in Serbia: regulated sectors can still achieve profitability when demand remains stable and operational discipline improves. For investors, this sector presents defensive investment characteristics rather than high-growth potential. Meanwhile, it serves as a reminder to policymakers that healthcare reform must encompass not only hospitals and insurers but also the retail segment that directly interacts with patients.
